The MPN (Myeloproliferative Neoplasm) panel by PCR is a molecular diagnostic test that detects specific mutations associated with MPNs. This panel includes the analysis of BCR-ABL, JAK2 exon 12-14, and EPO by CLIA. The test utilizes PCR (Polymerase Chain React...
The MPN (Myeloproliferative Neoplasm) panel by PCR is a molecular diagnostic test that detects specific mutations associated with MPNs. This panel includes the analysis of BCR-ABL, JAK2 exon 12-14, and EPO by CLIA. The test utilizes PCR (Polymerase C...
The MPN (Myeloproliferative Neoplasm) panel by PCR is a molecular diagnostic test that detects specific mutations associated with MPNs. This panel includes the analysis of BCR-ABL, JAK2 exon 12-14, and EPO by CLIA. The test utilizes PCR (Polymerase Chain Reaction) technology to amplify and identify these mutations in the patient's DNA. Detection of these mutations aids in the diagnosis, classification, and monitoring of MPNs, such as chronic myeloid leukemia (CML), polycythemia vera (PV), essential thrombocythemia...
MPN Panel 8 includes Erythropoietin (EPO)+Jak 2 Exon 12-15, BCR-ABL Qualitative (t (9;22)).
Showing 2 of 2 tests
The Erythropoietin (EPO)+Jak 2 Exon 12-15 test is a genetic analysis that detects mutations in JAK2 gene exons 12–15, often associated with myeloproliferative disorders. It also measures erythropoietin (EPO) levels to assess whether increased red blood cell production is driven by these mutations or by secondary causes. This helps diagnose conditions like polycythemia vera and guides precise treatment planning.
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.